Carvedilol Pellets

(Product under development)
Carvedilol PelletsCarvedilol is a non-selective beta blocker/alpha-1 blocker indicated in the treatment of mild to moderate congestive heart failure (CHF).

And as a controlled-release formulation, marketed in the US as Coreg CR (GSK). Carvedilol was discovered by Robert R. Ruffolo, Jr. It has had a significant role in the treatment of Congestive heart failure.

Available Form:
Carvedilol Pellets
Carvedilol Granules

Umang Pharmatech equipments used for production of Carvedilol Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Carvedilol Pellets
Systematic (IUPAC) Name
Carvedilol Pellets
Carvedilol Pellets
Chemical data
CAS number : 72956-09-3
ATC code : C07AG02
PubChem : CID 2585
IUPHAR ligand : 551
DrugBank : APRD00091
ChemSpider : 2487
UNII : 0K47UL67F2
Formula : C24H26N2O4
Mol. mass : 406.474

* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech